Collectively, our findings provide new insights into the multifaceted role of ETV4 in tumor biology and immune regulation and lay the groundwork for future studies aimed at validating ETV4 as a biomarker and potential therapeutic target across cancers. The gene discussed is ETV4; the disease is cancer.